Trials / Completed
CompletedNCT02592057
Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
A Multicenter, Prospective, Observational, Post Marketing Surveillance Study to Evaluate the Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Patients With Chronic Hepatitis C Virus Infection in India
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 532 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of sofosbuvir (SOF)-based regimens administered as per the approved prescribing information in adults with chronic hepatitis C virus (HCV) infection treated in routine clinical practice in India.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SOF | SOF tablets administered orally once daily based on approved prescribing information |
Timeline
- Start date
- 2015-11-30
- Primary completion
- 2017-11-30
- Completion
- 2018-04-23
- First posted
- 2015-10-30
- Last updated
- 2018-05-15
Locations
26 sites across 1 country: India
Source: ClinicalTrials.gov record NCT02592057. Inclusion in this directory is not an endorsement.